N/A
Completed N=20
Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation
Smoking Cessation · MindCotine Virtual Reality Mindful Exposure Therapy
Source: ClinicalTrials.gov NCT05220254 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Dec 2023
Primary outcomePrimary: Number of Patients Who Registered With the MindCotine Application — 9 Participants
Summary
This study aims to see how feasible a mobile app based virtual reality program for smoking cessation (MindCotine) would be among Stanford cancer center patients
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients Who Registered With the MindCotine Application |
9 | — |
| PRIMARY Number of Patients With Interest in the MindCotine Application |
27 | — |
| PRIMARY Number of Patients Who Would Recommend the MindCotine Application as a Measure of Feasibility Among Patients Who Smoke. |
7 | — |
| SECONDARY Number of Patients Who Attempt to Quit Smoking by Using the Application |
4 | — |
| SECONDARY Number of Patients Using Cessation Medication by End of Treatment |
5 | — |
| SECONDARY Number of MindCotine App Program Activities Completed |
13 | — |
| SECONDARY Number of MindCotine App Journal Entries Completed |
19 | — |
| SECONDARY Number of MindCotine App Coaching Engagements Completed |
11 | — |
| SECONDARY Average Change in Cigarette Use |
-4.1 | — |
| SECONDARY MindCotine Dropout |
5 | — |
Eligibility Criteria
Inclusion Criteria
- Daily cigarette smoker or some day smoker (>9 cigarettes per week)
- Age 18+
- English or Spanish fluent
- Smartphone compatibility
- Available to interact with a smartphone app for 6-weeks
- Available to complete the EOT assessment at end of 6-weeks
- Ability to understand and the willingness to personally sign the written IRB-approved informed consent document.
- Confirm phone, email, address during consent
Exclusion Criteria
- Ever had epilepsy
- Less than 10 cigarettes per week
- Not English or Spanish fluent
- No smartphone compatibility
- Unavailable to interact with the VR program,
- Unavailable to answer questions about the intervention post-treatment
Data sourced from ClinicalTrials.gov (NCT05220254). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.